Back to Authors

Curtis, Brenda

https://orcid.org/0000-0002-2511-3322

Mayo Clinic

National Institutes of Health

Citations 2

Insights into ALD and AUD diagnosis and prognosis: Exploring AI and multimodal data streams
Narayanan, Praveena , Wu, Tiffany , Shah, Vijay H. , Curtis, Brenda , Curtis, Brenda L , Wu, Tiffany

Hepatology | May 14, 2024 | Volume: 80 | Issue: 6 | Pages: 1480-1494

10.1097/hep.0000000000000929 Get It

The rapid evolution of artificial intelligence and the widespread embrace of digital technologies have ushered in a new era of clinical research and practice in hepatology. Although its potential is far from realization, these significant strides have generated new opportunities to address existing gaps in the delivery of care for patients with liver disease. In this review, we discuss how artificial intelligence and opportunities for multimodal data integration can improve the diagnosis, prognosis, and management of alcohol-associated liver disease. An emphasis is made on how these approaches will also benefit the detection and management of alcohol use disorder. Our discussion encompasses challenges and limitations, concluding with a glimpse into the promising future of these advancements.
Smartphone sensor data estimate alcohol craving in a cohort of patients with alcohol-associated liver disease and alcohol use disorder
Wu, Tiffany , Sherman, Garrick , Giorgi, Salvatore , Thanneeru, Priya, Ungar, Lyle , Kamath, Patrick S. , Curtis, Brenda , Shah, Vijay H. , Ungar, Lyle H , Simonetto, Douglas A , Curtis, Brenda L , Wu, Tiffany , Simonetto, Douglas A.

Hepatology Communications | December 7, 2023 | Volume: 7 | Issue: 12 | Pages: No page available

10.1097/hc9.0000000000000329 Get It

Background: Sensors within smartphones, such as accelerometer and location, can describe longitudinal markers of behavior as represented through devices in a method called digital phenotyping. This study aimed to assess the feasibility of digital phenotyping for patients with alcohol-associated liver disease and alcohol use disorder, determine correlations between smartphone data and alcohol craving, and establish power assessment for future studies to prognosticate clinical outcomes. Methods: A total of 24 individuals with alcohol-associated liver disease and alcohol use disorder were instructed to download the AWARE application to collect continuous sensor data and complete daily ecological momentary assessments on alcohol craving and mood for up to 30 days. Data from sensor streams were processed into features like accelerometer magnitude, number of calls, and location entropy, which were used for statistical analysis. We used repeated measures correlation for longitudinal data to evaluate associations between sensors and ecological momentary assessments and standard Pearson correlation to evaluate within-individual relationships between sensors and craving. Results: Alcohol craving significantly correlated with mood obtained from ecological momentary assessments. Across all sensors, features associated with craving were also significantly correlated with all moods (eg, loneliness and stress) except boredom. Individual-level analysis revealed significant relationships between craving and features of location entropy and average accelerometer magnitude. Conclusions: Smartphone sensors may serve as markers for alcohol craving and mood in alcohol-associated liver disease and alcohol use disorder. Findings suggest that location-based and accelerometer-based features may be associated with alcohol craving. However, data missingness and low participant retention remain challenges. Future studies are needed for further digital phenotyping of relapse risk and progression of liver disease.